Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00440
|
|||||
| Drug Name |
Sertraline
|
|||||
| Synonyms |
(+)-Sertraline; (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine; (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; Apo-Sertraline; CP 51974; Lustral; Lustral (TN); SRE; Sertralina; Sertralina [Spanish]; Sertraline (INN); Sertraline (Zoloft); Sertraline [INN:BAN]; Sertraline [Zoloft]; Sertralinum; Sertralinum [Latin]; Zoloft (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Depression [ICD11: 6A8Z] | Approved | [1] | |||
| Therapeutic Class |
Antidepressants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H17Cl2N
|
|||||
| Canonical SMILES |
CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
|
|||||
| InChI |
InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1
|
|||||
| InChIKey |
VGKDLMBJGBXTGI-SJCJKPOMSA-N
|
|||||
| CAS Number |
CAS 79617-96-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 306.2 | Topological Polar Surface Area | 12 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
4.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103213015
, 103937473
, 104342622
, 11372017
, 11374862
, 11484121
, 11488309
, 11490894
, 11493046
, 117463757
, 117475932
, 118047120
, 121264488
, 121363704
, 14776364
, 14923174
, 17425146
, 24723455
, 26753299
, 29215139
, 43125164
, 46505341
, 47870036
, 48019284
, 48243732
, 48394276
, 48416536
, 49665783
, 49699249
, 49995188
, 50105682
, 50105683
, 50105684
, 50105685
, 50723729
, 53788480
, 57288837
, 57316967
, 57654971
, 7849419
, 7980593
, 8192230
, 85148370
, 85789675
, 90341218
, 92714411
, 93166926
, 93167211
, 9455
, 99445038
|
|||||
| ChEBI ID |
ChEBI:9123
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Sertraline was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Improving the prediction of the brain disposition for orally administered drugs using BDDCS. Adv Drug Deliv Rev. 2012 Jan;64(1):95-109. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.